000 01367 a2200397 4500
005 20250513075924.0
264 0 _c19930222
008 199302s 0 0 eng d
022 _a0090-8258
024 7 _a10.1006/gyno.1993.1014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRusnati, M
245 0 0 _aEstro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium.
_h[electronic resource]
260 _bGynecologic oncology
_cJan 1993
300 _a88-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xmetabolism
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBlotting, Western
650 0 4 _aEndometrial Neoplasms
_xmetabolism
650 0 4 _aEndometrium
_xmetabolism
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aFibroblast Growth Factor 2
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMenopause
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aPlasminogen Activators
_xmetabolism
700 1 _aCasarotti, G
700 1 _aPecorelli, S
700 1 _aRagnotti, G
700 1 _aPresta, M
773 0 _tGynecologic oncology
_gvol. 48
_gno. 1
_gp. 88-93
856 4 0 _uhttps://doi.org/10.1006/gyno.1993.1014
_zAvailable from publisher's website
999 _c8422299
_d8422299